Evidence map›Paper›PMID 29367732›Full record

ArticleEuropean journal of clinical nutrition2018

Associations between 25-hydroxyvitamin D levels, body composition and metabolic profiles in young women.

Marjan Tabesh, Emma T Callegari, Alexandra Gorelik, Suzanne M Garland, Alison Nankervis, Asvini K Subasinghe, John D Wark, YFHI and Safe-D study groups

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical nutrition, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Marjan TabeshDepartment of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.
Emma T CallegariDepartment of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.
Alexandra GorelikDepartment of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.
Suzanne M GarlandInfection and Immunity Theme, Murdoch Childrens Research Institute, Melbourne, VIC, Australia.
Alison NankervisDepartment of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.
Asvini K SubasingheInfection and Immunity Theme, Murdoch Childrens Research Institute, Melbourne, VIC, Australia.
John D WarkDepartment of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia. jdwark@unimelb.edu.au.
YFHI and Safe-D study groups
The Royal Melbourne Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesCardiovascular disease (CVD) is a major cause of mortality and morbidity globally. Results from previous studies are inconsistent and it remains unclear whether low-serum 25 OHD levels are associated with an increased risk of CVD. These associations have been little studied in young women. The aim of this study was to assess the relationship between serum 25 OHD and obesity, body composition, metabolic profiles and blood pressure in young women. SUBJECTS/

methodsWomen aged 16-25 years living in Victoria, Australia, were recruited through Facebook advertising in this cross-sectional study. Participants completed an online survey and attended a site visit in a fasted state, where parameters, including blood pressure, anthropometry, metabolic profiles, serum 25 OHD levels and body composition (using dual energy X-ray absorptiometry) were measured.

resultsA total of 557 participants were recruited into this study. Multiple linear regression analysis showed that after adjusting for visceral fat, season, smoking, physical activity, age, alcohol intake, oral contraceptive use, country of birth, taking multivitamins and taking vitamin D supplement, a 10 nmol/L increase in 25 OHD levels was associated with 0.65% greater HDL levels (p = 0.016) and 0.92% greater triglyceride levels (p = 0.003). It was also associated with 0.48% lower BMI (p < 0.001), 0.50% lower total fat percentage (p < 0.001), 0.09% lower visceral fat percentage (p < 0.001), 0.14% lower visceral fat to total fat ratio (p < 0.001) and 0.36% lower trunk fat to total fat ratio (p < 0.001), after adjustment for season, smoking, physical activity, age, alcohol intake, oral contraceptive use, country of birth, taking multivitamins and taking vitamin D supplements. Although these associations were statistically significant, they were very small in magnitude and of uncertain clinical significance.

conclusionsThese findings may help to explain an association between 25 OHD levels and CVD risk factors through associations with HDL, BMI, total body and visceral fat mass. Possible underlying mechanisms warrant further investigation.

Indexed as

AdolescentAdultBlood PressureBody CompositionBody Mass IndexCholesterolCholesterol, HDLCross-Sectional StudiesFemaleHumansIntra-Abdominal FatMetabolomeObesityTriglyceridesVictoriaVitamin D25-hydroxyvitamin DCholesterolCholesterol, HDLTriglyceridesVitamin D

Identifiers

PMID29367732
OpenAlexW2789796024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.